• December 8, 2025

Welldoc Partners with CLEAR to Integrate Secure Identity Verification in AI-Powered Cardiometabolic Health Platform

Collaboration Advances CMS Health Tech Ecosystem Goals by Enabling Seamless, Secure Access to Health Data for Personalized Chronic Disease Management...

Read More

• November 13, 2025

Welldoc Cements AI Leadership with Dedicated AI Lab and 100+ Clinical Publications

Welldoc's Strategic Investment Accelerates Research and Development of Novel AI-Powered Hyper-personalization Capabilities at Scale ...

Read More

• October 15, 2025

Welldoc Expands AI-Powered Cardiometabolic Platform to Include Chronic Kidney Disease and MASH Support

The AI-powered platform elevates cardiometabolic care by extending its best-in-class weight management support to CKD and MASH....

Read More

• July 22, 2025

Welldoc and Databricks Strengthen Strategic Partnership to Enhance Welldoc’s AI-Driven Personalized Cardiometabolic Digital Health Solutions

Joins Databricks' Built on Partner Program to Expand Market Strategy and Enhance Data Intelligence in Regulated Healthcare Solutions...

Read More

• June 18, 2025

Welldoc Recognized by Modern Healthcare as one of the Best Places to Work in Healthcare in 2025

Read More

• June 4, 2025

Welldoc Works with Lilly to Launch a New Personalized Health & Medicine Platform for Those Prescribed Lilly’s Incretin Therapies

Providing Cardiometabolic Digital Health Support for Patients prescribed Zepbound^® (tirzepatide) or Mounjaro^®(tirzepatide) ...

Read More